Feasibility and safety of dobutamine stress echocardiography: Experience in 1000 patients;PRAKTIKABILITAT UND SICHERHEIT DER DOBUTAMIN-STRESSECHOKARDIOGRAPHIE: ERFAHRUNGEN BEI 1000 UNTERSUCHUNGEN

Zeitschrift fur Kardiologie

Volumn 85, Issue 1, 1996, Pages 28-34

  Zahn, R ^a   Lotter, R ^a   Nohl H ^a   Schiele, R ^a   Bergmeier, C ^a   Zander, M ^a   Seidl, K ^a   Senges, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

adverse effects; dobutamine stress echocardiography; safety

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXERCISE; FEASIBILITY STUDY; FEMALE; HEADACHE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; SAFETY; SEIZURE; VERTIGO;

ADULT; AGED; CORONARY DISEASE; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030043861     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA (1995) Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91:663-670
2. Armstrong WF (1991) Stress echocardiography for detection of coronary artery disease. Circulation 84, Suppl 1:43-49
3. Baudhuin T, Marwick T, Melin J, Wijns W, D'Hondt AM, Detry JM (1993) Diagnosis of coronary artery disease in elderly patients: safety and efficacy of dobutamin echocardiography. Eur Heart J 14:799-803
4. Berthe C, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J, Kulbertus HE (1986) Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 58:1167-1172
5. L'Abbate A (1991) Pathophysiological basis for noninvasive functional evaluation of coronary stenosis. Circulation 83. Suppl 3:2-7
6. Jaarsma W, Sutherland G, on behalf of the European Arbutamine Study Group (1992) Computerized closed loop delivery of arbutamine, a new agent for the diagnosis of coronary artery disease. Circulation 86, Suppl 1:126 (abstract)
7. Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF (1993) Paradoxic hypotension during dobutamine stress echocardiography: Clinical and diagnostic implications. J Am Coll Cardiol 21:1080-1086
8. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR (1992) Comparison of adenosine, dipyramidole, and dobutamine in stress echocardiography. Ann Intern Med 116:190-196
9. Mazeika PK, Nadazdin A, Oakley CM (1992) Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 19:1203-1211
10. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H (1993) Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88: 15-19
11. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezutto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M (1995) Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 91:2556-2565
12. Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik J (1992) Dynamic intraventricular obstruction during dobutamine stress echocardiography. Circulation 86:1429-1432
13. Picano E, Lattanzi F (1991) Dipyramidol echocardiography. A new diagnostic window on coronary artery disease. Circulation 83, Suppl 3:19-26
14. Picano E, Pingitore A, Conti U, Koahova M, Boem A, Cabani E, Ciuti M, Diastant A, L'Abbate A (1993) Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyramidole echocardiography. Eur Heart J 14:1216-1222
15. Picano E, Marini C, Pirelli S, et al, on behalf of the Echo-Persamine International Cooperative Study Group (1992) Safety of intravenous high-dose dipyramidole echocardiography. Am J Cardiol 70:252-258
16. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH, Arnese M, Roelandt JRTC (1994) Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 73:456-459
17. Poldermans D, Fioretti PM, Forster PM, Thomson IR, Boersma E, El-Said ME, du Bois NAIJ, Roelandt JRTC, van Urk H (1993) Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 87:1506-1512
18. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, Fineberg NS, Armstrong WF, Feigenbaum H (1991) Echocardiography detection of coronary artery disease during dobutamine infusion. Circulation 83:1605-1614
19. Schartl M, Beckmann S, Boksch W (1994) Streßechokardiographie - eine Standortbestimmung. Z Kardiol 83:531-547
20. Schröder K, Völler H, Hansen B, Levenson B, Wilkenshoff U, Schröder R (1992) Streß-Echokardiographie als Routine-Untersuchung bei koronarer Herzerkrankung. Dtsch Med Wschr 117:1583-1588
21. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H (1992) Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 19:1197-1202